Coronary Artery Disease (CAD) (Ischemic Heart Disease) Market Size, Pipeline Review and Analysis Report 2017
Coronary artery disease (CAD) is the most common type of heart disease. CAD happens when the arteries that supply blood to heart muscle become hardened and narrowed. Coronary artery disease (CAD) is the most common type of heart disease. CAD happens when the arteries that supply blood to heart muscle become hardened and narrowed.
Coronary Artery Disease (CAD) (Ischemic Heart Disease) Market Size, Pipeline Review and Analysis Report 2017 “The latest Pharmaceutical and Healthcare disease pipeline guide Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2017, provides an overview of the Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) pipeline landscape.” Summary The latest Pharmaceutical and Healthcare disease pipeline guide Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2017, provides an overview of the Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) pipeline landscape. Coronary artery disease (CAD) is the most common type of heart disease. CAD happens when the arteries that supply blood to heart muscle become hardened and narrowed. This is due to the buildup of cholesterol and other material, called plaque, on their inner walls. This buildup is called atherosclerosis. As it grows, less blood can flow through the arteries. As a result, the heart muscle can't get the blood or oxygen it needs. This can lead to chest pain (angina) or a heart attack. Most heart attacks happen when a blood clot suddenly cuts off the hearts' blood supply, causing permanent heart damage. The most common symptom of coronary artery disease is angina, or chest pain. Other symptoms include shortness of breath, palpitations, a faster heartbeat, weakness or dizziness, nausea and sweating. Complete Report Available @ http://www.radiantinsights.com/research/coronaryartery-disease-cad-ischemic-heart-disease-pipeline-review-h1-2017 Follow Us:
- Page 2 and 3: Report Highlights The Pharmaceutica
<strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong><br />
<strong>Heart</strong> <strong>Disease</strong>) <strong>Market</strong> <strong>Size</strong>, <strong>Pipeline</strong> <strong>Review</strong><br />
<strong>and</strong> <strong>Analysis</strong> <strong>Report</strong> <strong>2017</strong><br />
“The latest Pharmaceutical <strong>and</strong> Healthcare disease<br />
pipeline guide <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>)<br />
(<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) - <strong>Pipeline</strong> <strong>Review</strong>, H1<br />
<strong>2017</strong>, provides an overview of the <strong>Coronary</strong> <strong>Artery</strong><br />
<strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>)<br />
(Cardiovascular) pipeline l<strong>and</strong>scape.”<br />
Summary<br />
The latest Pharmaceutical <strong>and</strong> Healthcare disease pipeline guide <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>)<br />
(<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) - <strong>Pipeline</strong> <strong>Review</strong>, H1 <strong>2017</strong>, provides an overview of the <strong>Coronary</strong> <strong>Artery</strong><br />
<strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) (Cardiovascular) pipeline l<strong>and</strong>scape.<br />
<strong>Coronary</strong> artery disease (<strong>CAD</strong>) is the most common type of heart disease. <strong>CAD</strong> happens when the<br />
arteries that supply blood to heart muscle become hardened <strong>and</strong> narrowed. This is due to the<br />
buildup of cholesterol <strong>and</strong> other material, called plaque, on their inner walls. This buildup is called<br />
atherosclerosis. As it grows, less blood can flow through the arteries. As a result, the heart muscle<br />
can't get the blood or oxygen it needs. This can lead to chest pain (angina) or a heart attack. Most<br />
heart attacks happen when a blood clot suddenly cuts off the hearts' blood supply, causing<br />
permanent heart damage. The most common symptom of coronary artery disease is angina, or<br />
chest pain. Other symptoms include shortness of breath, palpitations, a faster heartbeat, weakness<br />
or dizziness, nausea <strong>and</strong> sweating.<br />
Complete <strong>Report</strong> Available @ http://www.radiantinsights.com/research/coronaryartery-disease-cad-ischemic-heart-disease-pipeline-review-h1-<strong>2017</strong><br />
Follow Us:
<strong>Report</strong> Highlights<br />
The Pharmaceutical <strong>and</strong> Healthcare latest pipeline guide <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong><br />
<strong>Heart</strong> <strong>Disease</strong>) - <strong>Pipeline</strong> <strong>Review</strong>, H1 <strong>2017</strong>, provides comprehensive information on the therapeutics<br />
under development for <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) (Cardiovascular),<br />
complete with analysis by stage of development, drug target, mechanism of action (MoA), route of<br />
administration (RoA) <strong>and</strong> molecule type. The guide covers the descriptive pharmacological action of<br />
the therapeutics, its complete research <strong>and</strong> development history <strong>and</strong> latest news <strong>and</strong> press<br />
releases.<br />
The <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) (Cardiovascular) pipeline guide also<br />
reviews of key players involved in therapeutic development for <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>)<br />
(<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) <strong>and</strong> features dormant <strong>and</strong> discontinued projects. The guide covers<br />
therapeutics under Development by Companies /Universities /Institutes, the molecules developed<br />
by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical <strong>and</strong> Discovery stages are<br />
3, 3, 17, 7, 18 <strong>and</strong> 1 respectively. Similarly, the Universities portfolio in IND/CTA Filed <strong>and</strong><br />
Discovery stages comprises 1 <strong>and</strong> 1 molecules, respectively.<br />
Request a Sample Copy of This <strong>Report</strong> @<br />
http://www.radiantinsights.com/research/coronary-artery-disease-cad-ischemic-heartdisease-pipeline-review-h1-<strong>2017</strong>/request-sample<br />
<strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) (Cardiovascular) pipeline guide helps in<br />
identifying <strong>and</strong> tracking emerging players in the market <strong>and</strong> their portfolios, enhances decision<br />
making capabilities <strong>and</strong> helps to create effective counter strategies to gain competitive advantage.<br />
The guide is built using data <strong>and</strong> information sourced from Global <strong>Market</strong>s Direct's proprietary<br />
databases, company/university websites, clinical trial registries, conferences, SEC filings, investor<br />
presentations <strong>and</strong> featured press releases from company/university sites <strong>and</strong> industry-specific third<br />
party sources. Additionally, various dynamic tracking processes ensure that the most recent<br />
developments are captured on a real time basis.<br />
Scope<br />
<br />
<br />
<br />
The pipeline guide provides a snapshot of the global therapeutic l<strong>and</strong>scape of <strong>Coronary</strong> <strong>Artery</strong><br />
<strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) (Cardiovascular).<br />
The pipeline guide reviews pipeline therapeutics for <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong><br />
<strong>Heart</strong> <strong>Disease</strong>) (Cardiovascular) by companies <strong>and</strong> universities/research institutes based on<br />
information derived from company <strong>and</strong> industry-specific sources.<br />
The pipeline guide covers pipeline products based on several stages of development ranging<br />
from pre-registration till discovery <strong>and</strong> undisclosed stages.<br />
Follow Us:
The pipeline guide features descriptive drug profiles for the pipeline products which comprise,<br />
product description, descriptive licensing <strong>and</strong> collaboration details, R&D brief, MoA & other<br />
developmental activities.<br />
The pipeline guide reviews key companies involved in <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong><br />
<strong>Heart</strong> <strong>Disease</strong>) (Cardiovascular) therapeutics <strong>and</strong> enlists all their major <strong>and</strong> minor projects.<br />
The pipeline guide evaluates <strong>Coronary</strong> <strong>Artery</strong> <strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>)<br />
(Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of<br />
administration (RoA) <strong>and</strong> molecule type.<br />
The pipeline guide encapsulates all the dormant <strong>and</strong> discontinued pipeline projects.<br />
The pipeline guide reviews latest news related to pipeline therapeutics for <strong>Coronary</strong> <strong>Artery</strong><br />
<strong>Disease</strong> (<strong>CAD</strong>) (<strong>Ischemic</strong> <strong>Heart</strong> <strong>Disease</strong>) (Cardiovascular)<br />
See More <strong>Report</strong>s of This Category by Radiant Insights @<br />
http://www.radiantinsights.com/catalog/pharmaceuticals-<strong>and</strong>-healthcare<br />
About Radiant Insights, Inc:<br />
Radiant Insights is a platform for companies looking to meet their market<br />
research <strong>and</strong> business intelligence requirements. We assist <strong>and</strong> facilitate<br />
organizations <strong>and</strong> individuals procure market research reports, helping them in<br />
the decision making process. We have a comprehensive collection of reports,<br />
covering over 40 key industries <strong>and</strong> a host of micro markets. In addition to over<br />
extensive database of reports, our experienced research coordinators also offer a<br />
host of ancillary services such as, research partnerships/ tie-ups <strong>and</strong> customized<br />
research solutions.<br />
Contact Details:<br />
Michelle Thoras<br />
Corporate Sales Specialist, USA<br />
Radiant Insights, Inc<br />
28 2nd Street, Suite 3036, San Francisco, CA 94105, United States<br />
Phone: 1-415-349-0054<br />
Toll Free: 1-888-202-9519<br />
Email: sales@radiantinsights.com<br />
Web: http://www.radiantinsights.com/<br />
Visit Our Blog: https://radiantinsightsinc.tumblr.com/<br />
Follow Us:
Change language